Transcript Guidelines
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines and Pharmaceutical Policies Department Health Services and Systems Cluster World Health Organization Teheran, 1-4 Nov. 08 Good Manufacturing Practices (GMP): an essential tool for improvement of safety GMP implementation in Blood/Plasma Establishments: a key element to Quality and safety of blood components Plasma contract fractionation programs Supporting access to blood plasma products 2 | HSS/EMP/BPB: Teheran, Oct 08 Assuring Blood/Plasma Safety: “Layers of Safety” 1. Donor selection criteria (epidemiological data) 2. Deferral procedures: national registries to avoid use of collections from previously unsuitable donors 3. Laboratory testing for infectious disease markers: selection of kits and validation 4. Implementation of GMPs in blood establishments 3 | HSS/EMP/BPB: Teheran, Oct 08 WORKSHOP OBJECTIVES 1. Facilitate understanding and added value of implementation of GMP concept in the context of blood establishments 2. Facilitate appropriate communication of blood establishments and regulatory authorities in the context of GMP 3. Identify countries needs to support GMP implementation 4. Assure input to the proposed WHO Guidelines for GMP in blood establishments 4 | HSS/EMP/BPB: Teheran, Oct 08 International Conference of Drug Regulatory Authorities (ICDRA): Recommendations Regulation of Blood and Blood-Derived Products: Global Challenges » Update legal provisions to strengthen blood products regulation » Facilitate GMP enforcement in blood and plasma establishments » Promote creation of regional networks of national authorities involved in the regulation of blood and blood products » Encourage development of risk-based regulatory strategies Scope: Blood Establishments and National Regulatory Authorities 5 | HSS/EMP/BPB: Teheran, Oct 08 International Conference of Drugblood Regulatory Emerging Diseases: regulating products Authorities (ICDRA): Recommendations, (ICDRA: Recommendations, BernBern 08) 2008 Recognizing the need worldwide for blood products regulation to ensure availability of safe blood and blood products in the face of known and emerging threats, including emerging infectious diseases, WHO should: » Prioritize development of Guidelines on GMP for Blood Establishments » Promote introduction of WHO recommended plasma standards by NRAs » Take steps to further develop and strengthen national/regional blood regulatory authorities and to promote cooperation Scope: Blood Establishments and National Regulatory Authorities 6 | HSS/EMP/BPB: Teheran, Oct 08 OUTLINE Overall Objectives To promote implementation of GMP by blood establishments Facilitate GMP enforcement in blood and plasma establishments Common GMP standard: a basis for mutual recognition of quality standards and inspections results between NRA's Promote introduction of blood products regulations 7 | HSS/EMP/BPB: Teheran, Oct 08